New Zealand approves medicinal use of ‘magic mushrooms'
WELLINGTON : New Zealand today approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called 'magic mushrooms'.
Deputy prime minister David Seymour said rules had been relaxed so psilocybin could be used to treat certain types of depression.
Psilocybin is a naturally occurring psychedelic compound found in some species of mushroom and can cause hallucinations and an altered state of mind.
'Psilocybin remains an unapproved medicine, but a highly experienced psychiatrist has been granted authority to prescribe it to patients with treatment-resistant depression,' Seymour said.
'This is huge for people with depression who've tried everything else and are still suffering.
'If a doctor believes psilocybin can help, they should have the tools to try.'
There will be tight rules for prescribing the drug.
Only psychiatrists who have been involved in psilocybin clinical trials will be allowed to prescribe it, and they must strictly report its use and keep detailed records.
Party drugs such as MDMA and magic mushrooms are increasingly being used in mainstream medical settings, helping treat post-traumatic stress disorder and depression.
Australia approved the medicinal use of psilocybin in 2023.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
a day ago
- Malay Mail
Australian man dies from ‘extremely rare' bat bite virus
SYDNEY, July 3 — An Australian man has died from an 'extremely rare' rabies-like infection transmitted by a bat bite, health officials said today. The man in his 50s was bitten by a bat carrying Australian bat lyssavirus several months ago, the health service in New South Wales said. 'We express our sincere condolences to the man's family and friends for their tragic loss,' NSW Health said in a statement. 'While it is extremely rare to see a case of Australian bat lyssavirus, there is no effective treatment for it.' The man from northern New South Wales, who has not been identified, was this week listed as being in a 'critical condition' in hospital. Officials said he was treated following the bite and they were investigating to see whether other exposures or factors played a role in his illness. The virus — a close relative to rabies, which does not exist in Australia — is transmitted when bat saliva enters the human body through a bite or scratch. First symptoms can take days or years to appear. Early signs of the disease are flu-like — a headache, fever and fatigue, the health service said. The victim's condition rapidly deteriorates, leading to paralysis, delirium, convulsions and death. There were only three previous cases of human infection by Australian bat lyssavirus since it was first identified in 1996 — all of them fatal. 'Coma and death' People should avoid touching or handling bats, as any bat in Australia could carry lyssavirus, the New South Wales health service said. Only wildlife handlers who are trained, protected, and vaccinated should interact with the flying mammals, it warned. 'If you or someone you know is bitten or scratched by a bat, you need to wash the wound thoroughly for 15 minutes right away with soap and water and apply an antiseptic with anti-virus action,' it said. 'Patients then require treatment with rabies immunoglobulin and rabies vaccine.' The virus has been found in species of flying foxes and insect-eating microbats, NSW Health said. The type of bat involved in the latest fatality has not been identified. Australian bat lyssavirus was first identified in May 1996 by scientists at the national science agency CSIRO, who examined brain tissue from a flying fox that had been showing 'nervous signs' in New South Wales. Later that year, a bat handler in Queensland became ill. 'The initial numbness and weakness suffered in her arm progressed to coma and death,' the science agency said in an online document on the virus. 'Two further cases in Queensland — a woman in 1998 and an eight year old boy in 2013 — resulted in death after being bitten or scratched by a bat,' it said. There are subtle differences between the lyssavirus in flying foxes and insectivorous bats, the science agency has found. Infected bats can transmit the virus to people, other bats and other mammals. — AFP
Free Malaysia Today
a day ago
- Free Malaysia Today
Australian dies from ‘extremely rare' bat bite virus
Infected bats can transmit the lyssavirus to people, other bats and other mammals. (AFP pic) SYDNEY : An Australian man has died from an 'extremely rare' rabies-like infection transmitted by a bat bite, health officials said today. The man in his 50s was bitten by a bat carrying Australian bat lyssavirus several months ago, the health service in New South Wales said. 'We express our sincere condolences to the man's family and friends for their tragic loss,' NSW Health said in a statement. 'While it is extremely rare to see a case of Australian bat lyssavirus, there is no effective treatment for it.' The man from northern New South Wales, who has not been identified, was this week listed as being in a 'critical condition' in hospital. Officials said he was treated following the bite and they were investigating to see whether other exposures or factors played a role in his illness. The virus – a close relative to rabies, which does not exist in Australia – is transmitted when bat saliva enters the human body through a bite or scratch. First symptoms can take days or years to appear. Early signs of the disease are flu-like – a headache, fever and fatigue, the health service said. The victim's condition rapidly deteriorates, leading to paralysis, delirium, convulsions and death. There were only three previous cases of human infection by Australian bat lyssavirus since it was first identified in 1996 – all of them fatal. 'Coma and death' People should avoid touching or handling bats, as any bat in Australia could carry lyssavirus, the New South Wales health service said. Only wildlife handlers who are trained, protected, and vaccinated should interact with the flying mammals, it warned. 'If you or someone you know is bitten or scratched by a bat, you need to wash the wound thoroughly for 15 minutes right away with soap and water and apply an antiseptic with anti-virus action,' it said. 'Patients then require treatment with rabies immunoglobulin and rabies vaccine.' The virus has been found in species of flying foxes and insect-eating microbats, NSW Health said. The species of bat involved in the latest fatality has not been identified. 'Australian bat lyssavirus is very closely related to rabies and will cause death in susceptible people if they become infected and are not treated quickly,' said James Gilkerson, infectious diseases expert at the University of Melbourne. The virus was first identified in May 1996 by scientists at the national science agency CSIRO, who examined brain tissue from a flying fox that had been showing 'nervous signs' in New South Wales. Later that year, a bat handler in Queensland became ill. 'The initial numbness and weakness suffered in her arm progressed to coma and death,' the science agency said in an online document on the virus. 'Two further cases in Queensland – a woman in 1998 and an eight year old boy in 2013 – resulted in death after being bitten or scratched by a bat,' it said. There are subtle differences between the lyssavirus in flying foxes and insectivorous bats, the science agency has found. Infected bats can transmit the virus to people, other bats and other mammals.
The Sun
a day ago
- The Sun
BeauEver Secures NZ Prime Minister's Support in Historic China Summit to Accelerate Global Skincare Expansion
SHANGHAI, CHINA - Media OutReach Newswire - 2 July 2025 - At the 2025 China–New Zealand Trade Innovation Summit, New Zealand Prime Minister, the Right Hon. Christopher Luxon, witnessed the official signing of a strategic partnership between high-end anti-aging brand BeauEver and biotechnology leader The Beauty Lab Collective (TBLC). This milestone partnership deepens economic cooperation between New Zealand and China while promoting the global development of responsible, science-driven skincare innovation. 'This partnership reflects the strength of the NZ–China relationship and our commitment to global innovation,' said Prime Minister Luxon. 'BeauEver represents the best of New Zealand — science, sustainability, and international vision.' The agreement includes the launch of a New Zealand-based Active Ingredient Innovation Center, dedicated to researching marine and botanical compounds native to New Zealand's pristine ecosystems. Through TBLC's certified cruelty-free infrastructure and intelligent manufacturing, BeauEver aims to enhance its capacity to meet the evolving needs of consumers in China and across Southeast Asia. 'Our mission is to become a globally trusted name in cellular anti-aging — where nature meets science, and skincare becomes a meaningful, restorative ritual. This partnership helps us share that philosophy with more women around the world.' said Liam Corkery, General Manager of BeauEver New Zealand. BeauEver's innovation is grounded in more than 40 years of research into bioactive ingredients and cell-level rejuvenation. With dual R&D centers in Switzerland and New Zealand, the brand focuses on holistic skin renewal by supporting mitochondrial vitality, collagen stimulation, and skin-barrier reinforcement. At the heart of its product line is the BeauEver Cell-Reviving Firming and Rejuvenating Essence — a lightweight, high-efficacy formula designed to support skin's natural renewal process. Powered by bio-fermented actives, transdermal collagen delivery, and barrier-enhancing peptides, the essence helps improve the appearance of firmness, radiance, and resilience over time. It embodies BeauEver's brand philosophy: to awaken the body's natural energy and deliver visible results with integrity, science, and care. With a reported 300% year-on-year growth in 2024 in China market, BeauEver is rapidly expanding its global footprint in the premium skincare space — particularly among dermatology clinics, spa professionals, and wellness institutions across Asia-Pacific.
